Additionally, SLC3A2 was a target gene of ZEB1 in breast cancer chemoresistance, it maybe the chemotherapy of laryngeal carcinoma is associsated with the result of high SLC3A2 patients with longer survival. The gene discussed is ZEB1; the disease is breast cancer.